Travis Gulledge, PhD
About Travis Gulledge, PhD
Travis Gulledge, PhD, is a Principal Scientist at StrideBio, Inc., specializing in the development and optimization of immunoassays to assess immune responses to rAAV vectors. He holds a PhD in Immunology and has extensive experience in immunological research and study design.
Work at StrideBio
Travis Gulledge, PhD, currently serves as Principal Scientist at StrideBio, Inc., a position he has held since 2021. In this role, he develops and optimizes in vitro and ex vivo immunoassays to evaluate immune responses to recombinant adeno-associated virus (rAAV) vectors. He also provides strategic direction for evaluating and modulating immune responses to AAV vectors. His responsibilities include assisting with in vivo study designs to assess immunological endpoints and analyzing and interpreting study results related to immune responses.
Education and Expertise
Travis Gulledge earned his Bachelor’s Degree in Biochemistry and a Doctor of Philosophy (Ph.D.) in Immunology from North Carolina State University. His academic background provides a strong foundation for his research and development work in immunology, particularly in relation to AAV vectors. His expertise encompasses the development of immunoassays and the analysis of immune responses, which are critical in the field of gene therapy and vaccine development.
Background
Before joining StrideBio, Travis Gulledge worked at Burleson Research Technologies, Inc. (BRT) as a Study Director from 2017 to 2021. In this role, he managed research studies and contributed to the understanding of immunological responses. Prior to that, he was an Immunology Doctoral Student at North Carolina State University from 2012 to 2017, where he focused on advanced research in immunology. His earlier experience includes working as a Laboratory Research Associate at Charles River Laboratories from 2009 to 2012.
Professional Experience
Travis Gulledge has accumulated significant professional experience in the field of immunology. He transitioned from a Laboratory Research Associate at Charles River Laboratories to an Immunology Doctoral Student at North Carolina State University. After completing his Ph.D., he took on the role of Study Director at Burleson Research Technologies, Inc. He briefly served as a Senior Scientist at StrideBio, Inc. before advancing to his current position as Principal Scientist.